Skip to main content

High-Dose Methotrexate in Combination Chemotherapy for Small Cell Lung Cancer

  • Chapter
Cancer Chemo- and Immunopharmacology

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 74))

Summary

High-dose methotrexate and Leucovorin (calcium folinate) rescue was evaluated as induction chemotherapy in combination with cyclophosphamide, doxorubicin, and vincristine in 21 patients with extensive-stage small cell lung cancer. Nine (42%) of 21 had a complete remission. The median duration of remission has been short (5 months), and attempts are now under way to improve consolidation chemotherapy. In general, the degree of myelotoxicity was not increased by the high-dose methotrexate, although the antitumor activity of the combination appears enhanced. Attempts at further increasing the intensity of this regimen or comparative trials with other therapy appears warranted.

This research was supported in part by JFCF, ACS 394; PHSG 5M01 RR-95; Division of Cancer Treatment of the National Cancer Institute

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abeloff MD, Ettinger DS, Khouri N (1970) Intensive induction therapy for small cell carcinoma of the lung (SCC). Proc Am Soc Clin Oncol 20:328

    Google Scholar 

  2. Brereton HD, Kent CA, Johnson RE (1977) Chemotherapy and radiotherapy for small cell lung cancer: A remedy for past therapeutic failure. Proc Am Soc Clin Oncol 18:275

    Google Scholar 

  3. Broder LE, Cohen MH, Selawry OS (1977) Treatment of bronchogenic carcinoma II. Small cell lung cancer. Cancer Treat Rev 4:219–260

    Article  PubMed  CAS  Google Scholar 

  4. Bunn PA, Cohen MH, Ihde DC, Fossieck BE, Matthews MJ, Minna JD (1977) Advances in small cell bronchogenic carcinoma. Cancer Treat Rep 61:333–342

    PubMed  Google Scholar 

  5. Cohen MH, Creaven PJ (1977) Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61:349–354

    PubMed  CAS  Google Scholar 

  6. Einhorn LH, Bond WH, Hornback N, Tekjoe B (1978) Long-term results in combined modality treatment of small cell carcinoma of the lung. Semin Oncol 5:309–313

    PubMed  CAS  Google Scholar 

  7. Greco FA, Brereton HD, Zimbler H, Merrill JM, Johnson RE (1976) Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 85:294–298

    PubMed  CAS  Google Scholar 

  8. Greco FA, Einhorn LH, Richardson RL, Oldham RK (1978) Small cell lung cancer: Progress and perspectives. Semin Oncol 5:323–335

    PubMed  CAS  Google Scholar 

  9. Greco FA, Richardson RL, Stroup SL, Shulman S, Oldham RK (1978) Therapy of oat-cell carcinoma of the lung: Complete remissions, acceptable complications and improved survival. Br Med J 2:10–11

    Article  PubMed  CAS  Google Scholar 

  10. Kent CH, Brereton HD, Johnson RE (1977) “Total” therapy for oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 2:427–432

    Article  PubMed  CAS  Google Scholar 

  11. Merrill JM, Brereton HD, Kent CH, Johnson RE (1976) Anorectal disease in patients with non-hematological malignancy. Lancet 1:1105–1107

    Article  PubMed  CAS  Google Scholar 

  12. Pitman E, Frei E (1977) Weekly methotrexate citrovorum (MTX-CF) with alkalinization: Tumor response in pase II study. Proc Am Assoc Cancer Res 18:124

    Google Scholar 

  13. Skarin A, Canellos G, Frei E (1978) Therapy of unfavorable histology non-Hodgkin’s lymphoma with high dose methotrexate and citovorum rescue, bleomycin, adriamycin, cyclophosphamide, Oncovin, and Decadron. Proc Am Soc Clin Oncol 19:400

    Google Scholar 

  14. Skarin A, Greene H, Canellos G, Takovrin R, Frei E (1979) High dose methotrexate with citrovorum factor rescue alternating with combination chemotherapy in small cell lung cancer. Proc Am Soc Clin Oncol 20:238

    Google Scholar 

  15. Stoller RG, Hande KR, Jacobs S, Chabner B (1977) Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N Engl J Med 297:630–633

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Greco, F.A., Hande, K.R., Richardson, R.L., Oldham, R.K. (1980). High-Dose Methotrexate in Combination Chemotherapy for Small Cell Lung Cancer. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81488-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81488-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81490-7

  • Online ISBN: 978-3-642-81488-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics